Ad

Sorrell praises Trump economy, warns about Amazon, China

Sorrell praises Trump economy, warns about Amazon, China

The former WPP chief executive shared his view on technology, the economy, and politics on Tuesday at Techonomy NYC 18.

Marketers share how they use ad safety tech to help pharma clients feel comfortable

Marketers discuss the role of ad safety tech in helping pharma clients feel comfortable with ads in non-endemic media.

Six weeks until the Cannes Lions: Here's what we know

Six weeks until the Cannes Lions: Here's what we know

Record year for brands, fewer celebrities, lower volume of entries expected and much more.

6 campaigns using real patients as advocates for orphan drugs

6 campaigns using real patients as advocates for orphan drugs

Dawn Hastings, associate creative director, Dudnyk, says using patients in campaigns for orphan drugs makes a brand's audience feel obligated to act.

Sorrell stayed too long as WPP chief executive

Sorrell stayed too long as WPP chief executive

By

Sir Martin Sorrell stayed too long as WPP chief executive, even before the personal conduct row that abruptly ended his tenure after 32 years.

Shortening the drug side-effect list, and five other ways pharma DTC is set to be reformed

Shortening the drug side-effect list, and five other ways pharma DTC is set to be reformed

By

MM&M hosted an event in Boston devoted to discussing topics and trends for the DTC marketer.

Read and Scott: 'We don't believe break-up of WPP makes sense'

Read and Scott: 'We don't believe break-up of WPP makes sense'

By

WPP's joint chief operating officers Mark Read and Andrew Scott have said they do not believe a break-up of the ad group makes sense.

Pro ad report 2017: Ad revenue plunged for print-first publishers

Pro ad report 2017: Ad revenue plunged for print-first publishers

The 2017 numbers aren't kind to print-first publishers. Is this a blip in print's fortunes or the start of a long-predicted decline?

DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

By

Following massive strikes by Opdivo and Keytruda, will more supersized campaigns follow?

DTC ads 2017: The good, the bad, and the ugly

DTC ads 2017: The good, the bad, and the ugly

By

We considered pharma and healthcare ads that, per iSpotTV, started airing no earlier than January 2017.

McCaskill takes aim at DTC ad tax deduction; measure expected to face stiff resistance

McCaskill takes aim at DTC ad tax deduction; measure expected to face stiff resistance

Pharma companies are likely to put up aggressive resistance to the measure, introduced earlier this month.

Five things for pharma marketers to know: Tuesday, August 29, 2017

Five things for pharma marketers to know: Tuesday, August 29, 2017

By

Drug ads make up to 38% of prime time commercials; Merck considers whether to pursue FDA approval for anacetrapib; BMS and Daiichi partner

PerfectLens sees ROI with programmatic ad buying

PerfectLens sees ROI with programmatic ad buying

By

The Canadian contact lens etailer partnered with a new technology vendor to look beyond its direct click-to-conversions.

Five things for pharma marketers to know: Friday, April 14, 2017

Five things for pharma marketers to know: Friday, April 14, 2017

By

Lawmaker wants better enforcement of TV ads placed by lawyers; more toddlers are taking antipsychotics; Neurocrine puts off price disclosure of new drug

How to Make DTC Ad 'Warnings' More Effective

How to Make DTC Ad 'Warnings' More Effective

A more general warning encourages consumers to engage in a personal discussion with their doctor about a drug, and it promotes engagement with longer-format printed or digitally-delivered information.